# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001140361-24-042194
Filing Date
2024-09-27
Accepted
2024-09-27 16:19:38
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | ny20034373x3_defa14a.htm | DEFA14A | 23163
2 |  | ny20034373x3_nc01.jpg | GRAPHIC | 497562
3 |  | ny20034373x3_nc02.jpg | GRAPHIC | 442912
| Complete submission text file | 0001140361-24-042194.txt |  | 1319101

Mailing Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065
Business Address 655 MADISON AVENUE 19TH FLOOR NEW YORK NY 10065 519.322.8800
Tilray Brands, Inc. (Filer) CIK: 0001731348 (see all company filings)

EIN.: 824310622 | Fiscal Year End: 0531
Type: DEFA14A | Act: 34 | File No.: 001-38594 | Film No.: 241335130
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)